Concepedia

Author

Axel‐R. Hanauske

Technical University of Munich

Also Known As

A HANAUSKE, A Hanauske, A R Hanauske, A. -R. Hanauske, A. Hanauske, A.-R Hanauske, A.-R. Hanauske, A.R Hanauske, A.R. Hanauske, Axel-R Hanauske

80

Publications

2.7K

Citations

26

H-Index

51

Concepts

All Affiliations

Technical University of MunichKlinikum rechts der IsarAsklepios Klinik St. GeorgThe University of Texas Health Science Center at San AntonioEuropean Organisation for Research and Treatment of Cancer
AH

About

Axel‐R. Hanauske is an author at Technical University of Munich specializing in medicine, pharmacology, and cancer research.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

18

24

1.2K

2

Biochemistry

2

2

183

3

Health Sciences

1

1

14

4

Natural Sciences

1

1

34

5

Allergy

1

1

19

Axel‐R. Hanauske

×

35

Publications

2K

Citations

23

H-Index

YearCitations

Docetaxel (Taxotere®): An active drug for the treatment of patients with advanced squamous cell carcinoma of the head and neck

G. Catimel, Jaap Verweij, Vera Mattijssen,

Annals of Oncology

1994

258

Activity of Topotecan, a New Topoisomerase I Inhibitor, Against Human Tumor Colony-Forming Units In Vitro

H.A. Burris, Axel‐R. Hanauske, Randall K. Johnson,

JNCI Journal of the National Cancer Institute

1992

170

Clinical and Pharmacokinetic Phase I Study of Multitargeted Antifolate (LY231514) in Combination With Cisplatin

R. Thödtmann, H. Depenbrock, Herlinde Dumez,

Journal of Clinical Oncology

1999

151

Inhibition of the G1-S transition of the cell cycle by inhibitors of deoxyhypusine hydroxylation

Hartmut M. Hanauske‐Abel, M.-H. Park, Axel‐R. Hanauske,

Biochimica et Biophysica Acta (BBA) - Molecular Cell Research

1994

149

Clinical phase I and pharmacokinetic trial of the new titanium complex budotitane

T. Schilling, K. B. Keppler, Manfred Heim,

Investigational New Drugs

1995

146

Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells

Axel‐R. Hanauske, Donna Degen, Susan G. Hilsenbeck,

Anti-Cancer Drugs

1992

125

Phase I and Pharmacokinetic Study of the Oral Farnesyl Transferase Inhibitor SCH 66336 Given Twice Daily to Patients With Advanced Solid Tumors

Ferry A.L.M. Eskens, Ahmad Awada, David L. Cutler,

Journal of Clinical Oncology

2001

118

Detection of a sub‐set of polysomal mRNAs associated with modulation of hypusine formation at the G1‐S boundary Proposal of a role for eIF‐5A in onset of DNA replication

Hartmut M. Hanauske‐Abel, Bozena Slowinska, Sylwia Zagulska,

FEBS Letters

1995

76

Biphasic Effect of Vanadium Salts on In Vitro Tumor Colony Growth

U. Hanauske, Axel‐R. Hanauske, Martha H. Marshall,

The International Journal Of Cell Cloning

1987

72

Phase I and pharmacokinetic study of BIBX 1382 BS, an epidermal growth factor receptor (EGFR) inhibitor, given in a continuous daily oral administration

Ch. Dittrich, G. Greim, Markus Borner,

European Journal of Cancer

2002

69

Page 1